Following IGF-I treatment, both western blotting and immunofluorescence observed obvious EMT marker switching, as shown by the downregulation of the epithelial marker E-cadherin and the upregulation of the mesenchymal marker vimentin in BGC-823 gastric cancer cells (P<0.05; Fig. 1B and C). This evidence concerns the gene VIM and gastric cancer.